Elevated fructosamine levels in acquired immunodeficiency syndrome

Endocrine Practice

Volumn 14, Issue 6, 2008, Pages 686-690

  Kabadi, Mary ^a   Kabadi, Udaya M ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; PLASMA PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; MALE; ORAL GLUCOSE TOLERANCE TEST; BLOOD; GLYCOSYLATION; METABOLISM; MIDDLE AGED;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; BLOOD PROTEINS; FRUCTOSAMINE; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 64749096515     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.6.686     Document Type: Article

References (31)

1. Kabadi UM, Gopal V, Hood L, Kabadi MU, Platt K. Elevated glycosylated hemoglobin concentrations in AIDS. AIDS. 1992;6:236-238.
2. Ricart W, Fernández-Real JM, del Pozo M, Mascaró J, García-Bragado F. The cause of elevated glycosylated haemoglobin concentrations in AIDS. AIDS. 1993;7:1274-1275.
3. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112:126-128.
4. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of human hemoglobin A1c: slow glycosylation in vivo. J Clin Invest. 1976;57:1652-1659.
5. Vintzileos AM, Thompson JP. Glycohemoglobin determinations in normal pregnancy and in insulin-dependent diabetes. Obstet Gynecol. 1980;56:435-439.
6. Kovarik J, Stummvoll HK, Graf H, Müller MM. Glucose intolerance and hemoglobin A1 in chronic renal failure. Nephron. 1981;28:209-212.
7. Smith RJ, Koenig RJ, Binnerts A, Soeldner JS, Aoki TT. Regulation of hemoglobin A1c formation in human erythrocytes in vitro: effects of physiologic factors other than glucose. J Clin Invest. 1982;69:1164-1168.
8. Huisman TH, Henson JB, Wilson JB. A new high-performance liquid chromatographic procedure to quantitate hemoglobin A1c and other minor hemoglobins in blood of normal, diabetic, and alcoholic individuals. J Lab Clin Med. 1983;102:163-173.
9. Hoberman HD. Post-translational modification of hemoglobin in alcoholism. Biochem Biophys Res Commun. 1983;113:1004-1009.
10. Zawada ET Jr, Johnson M, Mackenzie T, et al. Hemoglobin A1 in renal transplant recipients. Arch Intern Med. 1985;145:82-84.
11. Narayan KM, Pettitt DJ. Glycosylated hemoglobin in pregnancy. Diabetes Care. 1996;19:1455.
12. Snehalatha C, Ramachandran A, Satyavani K, Vijay V. Limitations of glycosylated haemoglobin as an index of glucose intolerance. Diabetes Res Clin Pract. 2000;47: 129-133.
13. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Torella R. A preliminary note on inhibiting effect of alpha-tocopherol (vit. E) on protein glycation. Diabete Metab. 1988;14:40-42.
14. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications? Diabetes Care. 1991;14:68-72.
15. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
16. Guggenheim MA, Ringel SP, Silverman A, Grabert BE. Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol. J Pediatr. 1982;100:51-58.
17. Austin GE, Mullins RH, Morin LG. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. Clin Chem. 1987;33:2220-2224.
18. Tietz NW. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia, PA: WB Saunders Co, 1995: 224-225.
19. Iglesias JI, Nasr SH, Markowitz GS, D'Agati VD. AIDS, nephrotic-range proteinuria, and renal failure. Kidney Int. 2006;69:2107-2110.
20. Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006;69:2243-2250.
21. Afhami S, Rasoulinejad M, Razeghi E, Shahriari S, Esmailpour N. Renal disorders of HIV-infected patients. Arch Iran Med. 2007;10:335-338.
22. Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23:741-746.
23. Smyth K, Affandi JS, McArthur JC, et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007;8:367-373.
24. Jowi JO, Mativo PM, Musoke SS. Clinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospital. East Afr Med J. 2007;84:67-76.
25. Sheth SG, Rao CV, Tselis A, Lewis RA. HIV-related peripheral neuropathy and glucose dysmetabolism: study of a public dataset. Neuroepidemiology. 2007;29:121-124.
26. Jabs DA, Van Natta ML, Holbrook JT, et al. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007;114:787-793.
27. Kabadi UM, Hood L. Increased glycation of hemoglobin in AIDS: relation to severity of the disorder. Diabetes Res. 1998;33:37-44.
28. Sestak K. Chronic diarrhea and AIDS: insights into studies with non-human primates. Curr HIV Res. 2005;3:199-205.
29. Hiramatsu N, Hiromura K, Shigehara T, et al. Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J Am Soc Nephrol. 2007;18:515-527.
30. Kabadi UM, Reust CS, Kabadi MU. Weight gain, improvement in metabolic profile, and CD4 count with insulin administration in an AIDS patient. AIDS Patient Care STDS. 2000;14:575-579.
31. Kabadi UM, Kabadi MU. Weight gain, improvements in metabolic profiles and immunogenicity with insulin or sulfonylurea administration in AIDS. Clin Drug Investig. 2004;24:287-294.